1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1: S5-20.
2. Goff DC, Gerstein HC, Ginsberg HN, et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007; 99: 4i–20i.
3. Genuth S, Alberti KGMM, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–3167.
4. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98: 378–384.
5. Farup CE, Leidy NK, Murray M, et al. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 1998; 21: 1699–1706.
6. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Am 1998; 27: 861–874, vi–vii.
7. Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 1999; 44: 1061–1075.
8. Samsom M, Smout AJ. Abnormal gastric and small intestinal motor function in diabetes mellitus. Dig Dis Basel Switz 1997; 15: 263–274.
9. Rothstein RD. Gastrointestinal motility disorders in diabetes mellitus. Am J Gastroenterol 1990; 85: 782–785.
10. Scarpello JH, Sladen GE. Diabetes and the gut. Gut 1978; 19: 1153–1162.
11. Mégraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993; 22: 73–88.
12. Buta N, Tanih N, Ndip R. Increasing trend of metronidazole resistance in the treatment of Helicobacter pylori infection: A global challenge. Afr J Biotechnol 2010; 9: 1115–1121.
13. Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996; 41: 458–461.
14. Perdichizzi G, Bottari M, Pallio S, et al. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 1996; 19: 149–154.
15. Kojecký V, Roubalík J, Bartoníková N. [Helicobacter pylori in patients with diabetes mellitus]. Vnitr Lek 1993; 39: 581–584.
16. Williams textbook of endocrinology . - NLM Catalog- NCBI, Available on https://www.ncbi.nlm. nih .gov / nlmcatalog /9010985 (accessed 22 January 2018).
17. Papamichael KX, Papaioannou G, Karga H, et al. Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol 2009; 15: 2701–2707.
18. Gulcelik NE, Kaya E, Demirbas B, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005; 28: 214–217.
19. Woodward M, Morrison C, McColl K. An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 2000; 53: 175–181.
20. Rosenstock SJ, Jørgensen T, Andersen LP, et al. Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 2000; 28: 32–40.
21. Xia HH, Talley NJ, Kam EP, et al. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1039–1046.
22. Ko GT, Chan FK, Chan WB, et al. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 2001; 27: 171–177.
23. Ojetti V, Pitocco D, Ghirlanda G, et al. [Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus]. Minerva Med 2001; 92: 137–144.
24. Clyne M, Labigne A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 1995; 63: 1669–1673.